• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number VBJR072502A
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Occlusion (1984)
Event Date 10/28/2020
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported to gore: on (b)(6) 2020, the patient was treated for stenotic occlusion in the superficial femoral artery using two gore® viabahn® endoprostheses.It was reported both devices were delivered in their intended location without issue.On the same date, post operation, occlusion of the devices was identified.The physician stated the suspected cause of the occlusions is unknown.A reintervention was performed to treat the stenosis.The patient tolerated the procedure.
 
Manufacturer Narrative
Added h6 investigation findings and investigation conclusion.
 
Manufacturer Narrative
D1/d2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10950639
MDR Text Key219957964
Report Number2017233-2020-01502
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00733132623792
UDI-Public00733132623792
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 07/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/20/2023
Device Model NumberVBJR072502A
Device Catalogue NumberVBJR072502A
Was Device Available for Evaluation? No
Date Manufacturer Received04/29/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-